SRX sierra rutile holdings limited
Add to My Watchlist 0.00% ! 17.5¢

Clinical Trial Objectives, page-2

  1. mac345
    110 Posts.
    clock Created with Sketch.
    17/03/15
    11:40
    Post #: 14926614
    yep to be honest I am a bit stunned, as I never thought OPFS was the endpoint.
    http://www.biomedcentral.com/1471-2407/14/897
    can see here it states primary endpoint is PFS, same as on the trial site. It does state that PFS in the liver is secondary, so perhaps that implies that OPFS is the primary endpoint? would appreciate comments on this.
    Thanks
    SRX Price at posting: $18.35 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.